ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 107

$281K Total Retail Price of All Prescriptions

Rank: 61 out of 107

299 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 299 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 383 365 1 5
SIMVASTATIN 320 309 2 2
FUROSEMIDE 303 283 3 3
METOPROLOL SUCCINATE 250 249 4 15
LISINOPRIL 246 212 5 4
HYDROCHLOROTHIAZIDE 231 228 6 14
WARFARIN SODIUM 222 163 7 8
VITAMIN D 213 213 8 81
CITALOPRAM HBR 204 201 9 9
METOPROLOL TARTRATE 189 179 10 7
DONEPEZIL HCL 184 184 11 10
OMEPRAZOLE 167 153 12 6
ATORVASTATIN CALCIUM 165 164 13 17
MAPAP 149 149 14 143
TRAZODONE HCL 147 141 15 22
ASPIR-LOW 140 127 16 175
MIRTAZAPINE 138 115 17 16
LEVOTHYROXINE SODIUM 133 122 18 1
DOK 129 117 19 107
GABAPENTIN 115 115 20 11
METFORMIN HCL 112 102 21 13
LANTUS 108 101 22 34
ISOSORBIDE MONONITRATE ER 100 100 23 30
ALLOPURINOL 90 90 24 48
DIOVAN 87 86 25 33
RANITIDINE HCL 82 81 26 41
HUMALOG 81 76 27 79
PRAVASTATIN SODIUM 77 77 28 32
SENNA 74 74 29 100
PHENYTOIN SODIUM EXTENDED 73 62 30 121
CLOPIDOGREL 73 66 30 29
KLOR-CON M20 71 71 32 45
BACLOFEN 71 53 32 64
PLAVIX 68 63 34 43
LOSARTAN POTASSIUM 66 63 35 36
FELODIPINE ER 66 63 35 300
SERTRALINE HCL 60 47 37 12
RISPERIDONE 57 57 38 26
ADVAIR DISKUS 57 57 38 47
HYDRALAZINE HCL 55 53 40 58
NAMENDA 54 54 41 19
ATENOLOL 51 51 42 21
BENICAR 51 51 42 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.